BackGalera Therapeutics Overview

Galera Therapeutics Inventory

Latest inventory for GRTX: $0.

Get informed when a big investor buys or sells

+ Follow
Inventory
$0.00

Peer trimmed avg / median

Loading

Galera Therapeutics Inventory History

Loading

Galera Therapeutics vs. peers: Inventory Comparison

Loading

Galera Therapeutics Inventory Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Galera Therapeutics (GRTX) FAQ

The latest inventory for GRTX is $0 as of March 2026. In the prior-year period, the figure was $0. Investors often review this figure alongside Galera Therapeutics's historical trend and sector peers before judging valuation or financial health.

Over the past year, GRTX's inventory moved from $0 to $0. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Galera Therapeutics's operating scale or balance-sheet position.

A inventory figure of $0 for GRTX is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting GRTX's inventory ($0), review year-over-year change from $0, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Galera Therapeutics's inventory against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.